title: Tabletted microspheres containing Cynara scolymus (var. Spinoso sardo) extract for the preparation of controlled release nutraceutical matrices.
abstract: Controlled release dosage forms based on tabletted microspheres containing fresh artichoke Cynara scolymus extract were performed for the oral administration of a nutritional supplement. Microspheres were prepared using a spray-drying technique; lactose or hypromellose have been chosen as excipients. Microspheres were characterized in terms of encapsulated extract content, size and morphology. Qualitative and quantitative composition of the extract before and after the spray process was determined. Compressed matrices (tablets) were prepared by direct compression of the spray-dried microspheres. In vitro release tests of microparticles and tablets prepared were carried out in both acidic and neutral media. Spray-drying is a good method to prepare microspheres containing the artichoke extract. The microspheres encapsulate an amount of extract close to the theoretical value. Particle size analyses indicate that the microparticles have dvs of approximately 6-7 microm. Electronic microscopy observations reveal that particles based on lactose have spherical shape and particles containing hypromellose are almost collapsed. The hydroalcoholic extract is stable to the microsphere production process: its polyphenolic composition (qualitative and quantitative) did not change after spraying. In vitro release studies show that microparticles characterized by a quick polyphenolic release both in acidic and neutral media due to the high water solubility of the carrier lactose. On the contrary, microspheres based hypromellose release only 20% of the loaded extract at pH 1.2 in 2 h and the total amount of polyphenols is released only after about further 6 h at pH 6.8. Matrices prepared tabletting lactose microspheres and hypromellose microparticles in the weight ratio 1:1 show a slow release rate, that lasts approximately 24 h. This one-a-day sustained release formulation containing Cynara scolymus extract could be proposed as a nutraceutical controlled release dosage form for oral administration.
authors.affiliation: Dipartimento di Scineze del Farmaco, University of Sassari, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Gavini
authors.forename: M C
authors.initials: MC
authors.lastname: Alamanni
authors.forename: M
authors.initials: M
authors.lastname: Cossu
authors.forename: P
authors.initials: P
authors.lastname: Giunchedi
mesh_terms: D000284:Administration, Oral; D031943:Cynara scolymus; D003692:Delayed-Action Preparations; D019587:Dietary Supplements; D004339:Drug Compounding / Q000379:methods; D005419:Flavonoids / Q000032:analysis; D008855:Microscopy, Electron, Scanning / Q000379:methods; D008863:Microspheres; D010316:Particle Size; D010636:Phenols / Q000032:analysis; D010936:Plant Extracts / Q000737:chemistry; D059808:Polyphenols
chemical_list: D003692:Delayed-Action Preparations; D005419:Flavonoids; D010636:Phenols; D010936:Plant Extracts; D059808:Polyphenols